Researchers report neuroblastoma tumors shrank in 80 percent of newly diagnosed, high risk patients involved in a clinical trail of an immunotherapy treatment.
Researchers have discovered six proteins in spinal fluid which could be used as biomarkers for Alzheimer's disease.
Researchers discovered all neuroblastomas arise from a single type of embryonic cell called sympathoblasts. The findings could lead to new avenues of treatment for the aggressive childhood cancer.
Researchers report on how exosomic miRNAs released within a tumor environment affect resistance to chemotherapy.
